RxDoctor Payments Data

Eric Stockwell, MD

Pain Medicine · Metairie, LANPI 1164926911

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Boston Scientific at 46.1% of the total. Reporting peaked in 2023 at $8,907 and has fallen 98.3% since, to $148 in 2025. Among pain medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,274in general payments, 2019–2025

Across 166 payments — averaging $110.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Medtronic$4K
  • Saluda Medical Americas, Inc.$3K
  • Nevro Corp.$932
  • Curonix LLC$846
  • Abbott$356
  • plus $1K from 14 others

What the payments were for

  • Travel & lodging$10,80159%
  • Food & beverage$7,39440%
  • Education$800%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,274 in reported general payments places this provider in the 90th percentile of 97 pain medicine providers in Louisiana.

See all pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$27,688
Medicare patients
76
Services billed
402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen318$42,829
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen785$30,590
BelbucaBuprenorphine Hcl13$12,530
OxycontinOxycodone Hcl23$8,364
Oxycodone Hcl177$2,800
Gabapentin145$2,297
Lidocaine15$2,127
Pregabalin129$2,034
Tizanidine Hcl77$1,223
Cyclobenzaprine Hcl77$1,129
Celecoxib41$705
Methocarbamol29$652
Morphine Sulfate ErMorphine Sulfate18$558
Duloxetine Hcl24$476
Baclofen36$439

Paid to pharmacies, not to this prescriber.

Other pain medicine in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →